These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37629280)

  • 21. Botox injection in treatment of sialorrhea in children with cerebral palsy.
    Ghazavi M; Rezaii S; Ghasemi M; Azin N; Reisi M
    Am J Neurodegener Dis; 2023; 12(3):97-102. PubMed ID: 37457841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
    Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
    Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual atropine drops for the treatment of pediatric sialorrhea.
    Rapoport A
    J Pain Symptom Manage; 2010 Nov; 40(5):783-8. PubMed ID: 20541902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Submandibular duct transposition for drooling in children: A Casuistic review and evaluation of grade of satisfaction.
    Sousa S; Rocha M; Patrão F; Pereira G; Reis S; Horta P; Salgado C; Santos MD
    Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():58-61. PubMed ID: 30174011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial experience from a multidisciplinary pediatric salivary gland disorder clinic.
    Ali SA; Haney J; Payne L; Grischkan JM
    Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1505-9. PubMed ID: 26231740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual administration of atropine eye drops for treating sialorrhea after stroke: A randomized controlled trial.
    Wang L; Li A; Zhang C; Ding X; Xu H
    J Stroke Cerebrovasc Dis; 2024 Oct; 33(12):108050. PubMed ID: 39366591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients.
    Jost WH; Steffen A; Berweck S
    Expert Rev Neurother; 2021 Oct; 21(10):1059-1068. PubMed ID: 34516331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sialorrhea & aspiration control - A minimally invasive strategy uncomplicated by anticholinergic drug tolerance or tachyphylaxis.
    Dohar JE
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():97-101. PubMed ID: 30554718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
    Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for drooling in children with cerebral palsy.
    Walshe M; Smith M; Pennington L
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008624. PubMed ID: 23152263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for drooling in children with cerebral palsy.
    Walshe M; Smith M; Pennington L
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008624. PubMed ID: 22336850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
    Bachrach SJ; Walter RS; Trzcinski K
    Clin Pediatr (Phila); 1998 Aug; 37(8):485-90. PubMed ID: 9729704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of drooling in individuals with neurodisability: a surgical experience.
    Crysdale WS; Raveh E; McCann C; Roske L; Kotler A
    Dev Med Child Neurol; 2001 Jun; 43(6):379-83. PubMed ID: 11409826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sialorrhea: a management challenge.
    Hockstein NG; Samadi DS; Gendron K; Handler SD
    Am Fam Physician; 2004 Jun; 69(11):2628-34. PubMed ID: 15202698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
    Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
    Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of drooling in adults with neurological conditions.
    Squires N; Wills A; Rowson J
    Curr Opin Otolaryngol Head Neck Surg; 2012 Jun; 20(3):171-6. PubMed ID: 22487791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral submandibular duct rerouting: assessment of results on drooling in cerebral palsy cases.
    Khadivi E; Ashraf Zadeh F; Bakhshaee M; Fooladvand T; Movahed SR; Nabavi SS; Afzal Aghaee M
    Auris Nasus Larynx; 2013 Oct; 40(5):487-90. PubMed ID: 23489831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Nebulized Glycopyrrolate on Posterior Drooling in Patients with Brain Injury: Two Cases of Different Brain Lesions.
    Lee ZI; Yu KJ; Lee DH; Hong SK; Woo SB; Kim JM; Park D
    Am J Phys Med Rehabil; 2017 Aug; 96(8):e155-e158. PubMed ID: 28081026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
    Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N
    Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.